This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

POZEN’s Digital Advisory Board To Speak At Annual EPharma Summit

POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, announced today that its Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare, is participating in the eleventh annual ePharma Summit, a conference showcasing healthcare industry experts’ views on the evolution of digital marketing and how to reach consumers and physicians through social and digital media. A POZEN-sponsored panel discussion titled, “Transforming the Pharma Industry – Breakthrough Perspectives from Digital Leaders,” will be held on Tuesday, February 7, 2012 from 10:50 – 11:25 a.m. at the Sheraton New York Hotel & Towers.

“POZEN and its Digital Advisory Board are excited to be among the distinguished attendees speaking at this prominent digital marketing event,” said Liz Cermak, Executive Vice President and Chief Commercial Officer, POZEN Inc., and moderator of the discussion. “Comprised of some of the most influential voices and thought-leaders in the digital and social media space, our board will share their diverse perspectives and experiences and offer valuable insight into how pharmaceutical companies can leverage new digital strategies to more effectively engage physician and patient audiences.”

During the session, the Digital Advisory Board members will share their experiences, offering their perspectives on how to evolve traditional pharmaceutical marketing to best meet the needs of target audiences. The Digital Advisory Board has been working alongside POZEN as it prepares for the launch and marketing of its lead compound PA32540, which is being investigated for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers. They have helped POZEN design the actual Launch Plan for the brand.

About the Digital Advisory Board

POZEN, a progressive, specialty pharmaceutical company, formed the Digital Advisory Board to help advance the Company’s vision of creating a new pharma commercial model.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.99 0.00%
FB $102.01 0.00%
GOOG $682.40 0.00%
TSLA $151.04 0.00%
YHOO $27.04 0.00%


Chart of I:DJI
DOW 15,973.84 +313.66 2.00%
S&P 500 1,864.78 +35.70 1.95%
NASDAQ 4,337.5120 +70.6750 1.66%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs